CRAIF - Japan Based Early Cancer Detection Startup Raises $22 Million in Series C.

Japan based early cancer detection startup Craif raises $22 Million in Series C to expand further in the US markets & further advance their R&D. Led by Ryuichi Onose(Co-Founder & CEO), Takao Yasui(Scientific Advisor & Co-Founder), Yuki Ichikawa(CTO), & Mika Mizunuma(COO), Craif is using Micro RNA to detect early stage cancer using non-invasive urine based test.